Phyu, Su MyatTseng, Chih-ChungSmith, Tim Andrew Davies2018-11-192018-11-192019-04Phyu, S M, Tseng, C-C & Smith, T A D 2019, 'CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor', Magnetic Resonance Materials in Physics, Biology and Medicine, vol. 32, no. 2, pp. 227-235. https://doi.org/10.1007/s10334-018-0719-30968-5243ORCID: /0000-0003-0338-8664/work/50858394Mendeley: f328a4ea-8236-39a9-87ec-f32d86b89fdfhttp://hdl.handle.net/2164/11459Open via Springer Compact Agreement Funding from the University of Aberdeen Development Trust is gratefully acknowledged. Professor Zanda is gratefully acknowledged for the use of his NMR system.91043126engSDG 3 - Good Health and Well-beingglycogen synthase kinase 3 (GSK3)CDP-choline31P nuclear magnetic resonance spectroscopylipidglucosecholineCholineGlycogen synthase kinase 331 P nuclear magnetic resonance spectroscopyGlucoseLipidAPOPTOSISGLYCOGEN-SYNTHASE KINASE-3TRANSPORTMETABOLISMPATHWAYPHOSPHATIDYLCHOLINEP-31 nuclear magnetic resonance spectroscopyR MedicineRCDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitorJournal article10.1007/s10334-018-0719-3http://www.mendeley.com/research/cdpcholine-accumulation-breast-colorectal-cancer-cells-treated-gsk3targeting-inhibitorhttps://abdn.pure.elsevier.com/en/en/researchoutput/cdpcholine-accumulation-in-breast-and-colorectal-cancer-cells-treated-with-a-gsk3targeting-inhibitor(08ff650b-0ad6-4315-aba9-72489694694c).html322